ZP is delighted to announce that the Group has acquired 5 patents from Sarissa Biomedical Ltd.
ABOUT SARISSA
Sarissa Biomedical was formed as a spin-out from Warwick University, that specialized in the development and production of novel biosensors for the measurement of neuroactive chemicals.
The patents in the portfolio are listed below:
- WO2004048603: Sensor Coating Method, ...enzyme encapsulation coating method that is used to make the biosensors...
- WO2008081193: Ruthenium Purple Biosensor...use of gold microelectrodes coated with ruthenium purple to make highly selective biosensors that function in blood...
- WO2014087137: Biosensor devices, ...covers the technology required to make SMARTCap and covers biosensor arrays made by the two previous patents that are integrated into a device. (SMARTCap enables measurement of analytes in commonly used blood collection tubes such as vacutainers.)
- WO2016198839: Purines as an indication of ischemia,...patent describes specific concentrations in blood that are indicative of hypoxia...
- WO2016198838: Purines threshold indicative of stroke, ...describes specific concentrations in blood that are indicative of stroke...